Effect of Abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - Observations from the TARGET trial

Ivan P. Casserly, Eric J. Topol, Gang Jia, Richard A. Lange, Christian Hamm, Bernhard Meier, Peter M. DiBattiste, Nasser Lakkis, Derek P. Chew, Gregg W. Stone, David J. Cohen, David J. Moliterno

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of Abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - Observations from the TARGET trial'. Together they form a unique fingerprint.

Medicine & Life Sciences